Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA bans red dye 3
FDA Bans Red Dye No. 3 From Food, Beverages and Ingested Drugs, Citing Link to Cancer in Lab Rats
After decades of debate, the Food and Drug Administration (FDA) has announced a ban on Red Dye No. 3, a synthetic food coloring that’s been linked to cancer in male lab rats. The decision comes after a petition filed in 2022 by advocacy groups,
FDA Bans Red Dye 3 On Cusp Of Potentially Big Changes In Food Industry
FDA’s ban on Red 3 is a shot across the bow to the food sector that could ironically help facilitate Kennedy’s pursuit of further changes.
FDA announces ban on Red No. 3 food dye. Which of your favorite food items contain it
The Food and Drug Administration said it is banning the use of Red No. 3, which is founds in over 3,000 products. Here's a list of a few items
FDA approves 20 ZYN Nicotine pouches
FDA authorizes Zyn nicotine pouches, cites lower risk than cigarettes
The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine pouches.
FDA Approves Marketing of Nicotine Pouches
Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products. Nicotine pouches -- small synthetic fiber pouches containing nicotine -- are designed to be placed between a person's gum and lip.
Philip Morris’s Zyn nicotine pouch isn’t safe, but FDA gives OK to marketing it
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine pouches.
AstraZeneca, Datroway and US FDA
US FDA approves AstraZeneca's drug for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday. The treatment, jointly developed with the Japanese company,
AstraZeneca’s Datroway approved in U.S. for HER2-negative breast cancer patients
DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease.
AstraZeneca Gets FDA Approval for Metastatic Breast Cancer Treatment Datroway
AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo. The Anglo-Swedish drugmaker on Friday said that the approval is for adult breast cancer patients who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease.
4h
FDA: This common cookware may contaminate your food; here’s why
The U.S. Food & Drug Administration (FDA) would like for people to be aware of the potential risks of using common cooking ...
18h
on MSN
FDA orders manufacturers to do a better job detecting bird flu in raw pet food
FDA wants pet food manufacturers to do a better job identifying possible signs of bird flu in raw foods such as uncooked meat ...
1d
on MSN
FDA's Suggested Change to Food Packaging Raises Concerns Among Experts
Newsweek spoke to experts about the FDA's suggestion to place nutrition information on the front of packaged foods.
8h
What will the FDA ban on red dye linked to cancer mean for business? Houston-area candy shops react.
Houston-area candy manufactures react to the U.S. Food and Drug Administration's ban on red dye linked to cancer.
3d
FDA wants food companies to put nutrition labels on the front of packaging. Why?
Nutrition labels on your favorite grocery items may soon sport a new look. The Food and Drug Administration announced a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback